Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F46KC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,974
Award facts
- Contract value 100% obligated
- $28,973.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,973.87 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This firm fixed-price, non-set-aside contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor with extensive experience delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's competitively awarded federal contract portfolio demonstrates versatility in fulfilling diverse federal medical supply needs, from small-value transactions to substantial orders exceeding $45,000. This specific delivery order for Ozempic, a diabetes management medication, reflects the company's role in supporting military healthcare initiatives through the DLA's pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DR26F46KC?
SPE2DR26F46KC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F46KC worth?
The government has obligated $28,974 on SPE2DR26F46KC.
Is contract SPE2DR26F46KC an order under another contract?
Yes. SPE2DR26F46KC is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F46KC competed?
The extent of competition for SPE2DR26F46KC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award